drugset / Trial / NCT03329118

Drug-drug Interaction Between Simvastatin and SHR3824

NCT03329118

Phase 1 Unknown 12 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

the purpose of thr study is to investigate the potential interation between multiple oral doses of SHR3824 and single oral dose of Simvastatin in healthy adult volunteers.

Timeline

Start
2017-11-24
Primary completion
2017-12-04
Completion
2017-12-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Henagliflozin Small molecule 10 mg Oral
Subject Simvastatin Small molecule 40 mg Oral